Unsupported off-label use of cancer therapies: New challenges in the era of biopharmaceuticals

Jonas A. De Souza, G. Caleb Alexander

Research output: Contribution to journalReview article

Original languageEnglish (US)
Pages (from-to)495-498
Number of pages4
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume11
Issue number5
DOIs
StatePublished - Oct 1 2011
Externally publishedYes

Keywords

  • cancer
  • cost
  • economics
  • evidence-based medicine
  • off-label

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)

Cite this